?

Kroll Mark W

Director
Haemonetics Corporation
US, Boston [HQ]
CIK 1259254

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
20,664
Price per Share :
$73.49
Equivalence :
$1,518,597.36

Transaction History

  • A
    Form 4
    20,664 Shares After Transaction
    Value : $n/a
    $0.0
    07/25/24
  • Footnotes:
    #1 The securities awarded are in the form of restricted stock units ("RSUs") issued pursuant to the Haemonetics Corporation Amended and Restated 2019 Long-Term Incentive Compensation Plan. The RSUs vest 100% on the first anniversary of the date of grant.
    #2 Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.